Abstract: Systems and methods for generating and tracking molecular digital signatures to ensure authenticity and integrity of NA molecules are disclosed. In some embodiments, a NA authentication system includes a NA authentication device coupled to one or more user devices. Methods for generating a signed NA sequence, validating a signed NA sequence, and detecting/correcting potential errors within a user allowable limit using a NA authentication system are disclosed. Methods for associating a signed NA sequence with a digital representation of the NA sequence, using a NA authentication system, are disclosed.

Abstract: The invention described herein is for generating executable program code manifesting a dataflow description in accordance with a set of nodes and links of a flow graph. More specifically, the invention is directed at generating, based on aggregating at least a subset of the plurality of task data objects that may be received, a dataflow description. The generated data flow description having at least one shared attribute. An executable program code may be generated to produce an output data object based on executing, by the processor, the executable program code manifesting the dataflow description.

Abstract: Systems and methods for generating and tracking molecular digital signatures to ensure authenticity and integrity of NA molecules are disclosed. In some embodiments, a NA authentication system includes a NA authentication device coupled to one or more user devices. Methods for generating a signed NA sequence, validating a signed NA sequence, and detecting/correcting potential errors within a user allowable limit using a NA authentication system are disclosed.

Abstract: The present invention provides methods for designing and verifying nucleic acid molecules having one or more desired properties. The methods are typically encoded into software, and typically include use of databases and algorithms to determine if nucleic acid molecules designed to have various elements in functional relationships have the intended properties. The result is achieved by determining if the various elements of the designed nucleic acid are in the correct order and physical relationship to other elements, and that the proper elements are selected. Computer systems for implementing the method, as well as business methods for reaping monetary gain from use of the methods, are also disclosed.

Abstract: A computer system and methods are provided for mapping genotypes to phenotypes. The system includes a molecular network model and an optimizer. Functions of the molecular network model called trait functions are implemented to compute simulated phenotypes of the network. Simulated phenotypes are numerical properties of the molecular network that correspond to observed phenotypes which are observable properties of the biological system represented by the molecular network model. The optimizer optimizes the network to fit simulated phenotypes to observed phenotypes. The genotype to phenotype mapping system is useful in prediction of phenotypes, identification of phenotypic differences among polymorphic genotypes, determination of environmental effects on phenotypic development, determination of differences in patient response to a therapeutic agent due to genetic polymorphism, and genetic engineering of a target phenotype.